VN
Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
$5.15 +0.59% (+$0.03)
1M -2.09%
Market Cap $309.7M
P/E Ratio -
Div. Yield -
ROE 84.95%
Bulios Fair Price
$6.17
19.8% upside
Trenutna cena
$5.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VNDA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
97 /100
Cheap P/S 1.44x
P/B 1.41x
P/E N/A
Growth
0 /100
Declining Rev. growth 5.29%
Book val. growth 14.70%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 92.82%
Net margin 127.41%
Op. margin 86.07%
Quality
7 /100
Poor ROIC 113.80%
ROE 84.95%
ROA 66.64%
Debt
94 /100
Low Debt/Equity 0.10x
Current ratio 1.61x
Int. coverage N/A
Stability
45 /100
Moderate Beta 0.65x
Rev. volatility 17.67%
EPS volatility 527.64%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VNDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mihael H. Polymeropoulos
Employees
533
Headquarters
Washington
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report